Assure Holdings to Present at the virtual Fall Investor Summit on November 16th-18th

Assure Holdings (OTC PINK:ARHH) will present at the virtual Fall Investor Summit on November 16-18, 2020.

Rhea-AI Summary

Assure Holdings (OTC PINK:ARHH) will present at the virtual Fall Investor Summit on November 16-18, 2020. This event features 75 companies and over 300 investors, aiming to connect small and microcap businesses with potential investors. In addition to its core business in intraoperative neurophysiological monitoring (IONM), Assure is launching a telehealth service for IONM. The company has performed over 6,400 procedures, generating $18 million in revenue during 2019, and is recognized for high-quality patient care.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, NY / ACCESSWIRE / November 12, 2020 / Assure Holdings (OTC PINK:ARHH), is a best-in-class provider of outsourced intraoperative neurophysiological monitoring (IONM), and is complementing its core business with a late 2020 launch of a telehealth offering for IONM services. ARHH will be presenting at this year's virtual Fall Investor Summit on November 16^th-18^th.

The Fall Investor Summit will take place virtually, featuring 75 companies and over 300 institutional and retail investors.

About Assure Holdings

Assure is a best-in-class outsourced provider of intraoperative neurophysiological monitoring (IONM) and professional neurologist oversight services as well as an emerging telehealth provider. The Company employs its own staff of technologists, uses its own state-of-the-art monitoring equipment and handles related operational functions including scheduling and billing. In addition, Assure is establishing a neurology telemedicine business to ensure quality of service for cases involving Assure patients and as an offering to other IONM providers. Assure Neuromonitoring operates across eight states, works with more than 100 neurosurgeons and orthopedic spine surgeons and performed over 6,400 procedures and generated $18 million in revenue during 2019. The Company is recognized as providing the highest level of patient care in the industry and has earned the Joint Commission's Gold Seal of Approval®. For more information, visit the company's website at www.assureneuromonitoring.com.

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors.

To register as a presenting company: please contact Brittney Blocker (brittney@investorsummitgroup.com)

To request complimentary investor registration: please visit our website at www.investorsummitgroup.com

News Compliments of ACCESSWIRE

FOR MORE INFORMATION

Please visit: www.investorsummitgroup.com

Or, contact Brittney Blocker at brittney@investorsummitgroup.com

SOURCE: Assure Holdings

View source version on accesswire.com:
https://www.accesswire.com/615946/Assure-Holdings-to-Present-at-the-virtual-Fall-Investor-Summit-on-November-16th-18th

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What will Assure Holdings present at the Fall Investor Summit?

Assure Holdings will present its telehealth offering for intraoperative neurophysiological monitoring services at the Fall Investor Summit.

When is the Fall Investor Summit where Assure Holdings will present?

The Fall Investor Summit will take place virtually from November 16 to November 18, 2020.

What services does Assure Holdings provide for IONM?

Assure Holdings provides outsourced intraoperative neurophysiological monitoring and professional neurologist oversight services.

What were Assure Holdings' revenue figures for 2019?

Assure Holdings generated $18 million in revenue and performed over 6,400 procedures in 2019.

How does Assure Holdings ensure quality patient care?

Assure Holdings employs its own staff of technologists and has earned the Joint Commission's Gold Seal of Approval for high-quality care.